Ekaterina S. Kuznetsova
Research Subjects
Ekaterina S. Kuznetsova has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
A.M. Galaktionova
2 shared publicationsA.S. Olenev
2 shared publicationsE.E. Baranova
2 shared publicationsE.N. Songolova
2 shared publications- Elena E. Baranova
Russian Medical Academy of Continuous Professional Education
2 shared publications - Galaktionova A.M. Galaktionova
LLC “Evogen”, Moscow, Russian Federation
2 shared publications
Latest Publications
- Open Access
- 9 August 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-11
Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies
Background: A fast adoption of a non–invasive prenatal testing (NIPT) in clinical practice is a global tendency last years. Firstly, in Russia according a new regulation it was possible to perform a widescale testing of pregnant women in chromosomal abnormality risk. The aim of the study—to assess efficiency of using NIPT as a second-line first trimester screening test in Moscow.Methods: Based on the first trimester combined prenatal screening results 12,700 pregnant women were classified as a high-risk (cut-off ≥ 1:100) and an intermediate-risk (cut-off 1:101 – 1:2500) groups followed by whole genome NIPT. Women from high-risk group and those who had positive NIPT results from intermediate-risk group were considered for invasive prenatal diagnostic.Results: 258 (2.0%) samples with positive NIPT results were detected including 126 cases of trisomy 21 (T21), 40 cases of T18, 12 cases of T13, 41 cases of sex chromosome aneuploidies (SCAs) and 39 cases of rare autosomal aneuploidies (RAAs) and significant copy number variations (CNVs). Statistically significant associations (p < 0.05) were revealed for fetal fraction (FF) and both for some patient’s (body mass index and weight) and fetus’s (sex and high risk of aneuploidies) characteristics. NIPT showed as a high sensitivity as specificity for common trisomies and SCAs with an overall false positive rate 0.3%.Conclusions: NIPT demonstrated high sensitivity and specificity. As a second-line screening test it has shown a high efficiency in detecting fetus chromosomal anomalies as well as it could potentially lower the number of invasive procedures in pregnant women.
- 9 August 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-11
Open AccessWhole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies
Background: A fast adoption of a non–invasive prenatal testing (NIPT) in clinical practice is a global tendency last years. Firstly, in Russia according a new regulation it was possible to perform a widescale testing of pregnant women in chromosomal abnormality risk. The aim of the study—to assess efficiency of using NIPT as a second-line first trimester screening test in Moscow.Methods: Based on the first trimester combined prenatal screening results 12,700 pregnant women were classified as a high-risk (cut-off ≥ 1:100) and an intermediate-risk (cut-off 1:101 – 1:2500) groups followed by whole genome NIPT. Women from high-risk group and those who had positive NIPT results from intermediate-risk group were considered for invasive prenatal diagnostic.Results: 258 (2.0%) samples with positive NIPT results were detected including 126 cases of trisomy 21 (T21), 40 cases of T18, 12 cases of T13, 41 cases of sex chromosome aneuploidies (SCAs) and 39 cases of rare autosomal aneuploidies (RAAs) and significant copy number variations (CNVs). Statistically significant associations (p < 0.05) were revealed for fetal fraction (FF) and both for some patient’s (body mass index and weight) and fetus’s (sex and high risk of aneuploidies) characteristics. NIPT showed as a high sensitivity as specificity for common trisomies and SCAs with an overall false positive rate 0.3%.Conclusions: NIPT demonstrated high sensitivity and specificity. As a second-line screening test it has shown a high efficiency in detecting fetus chromosomal anomalies as well as it could potentially lower the number of invasive procedures in pregnant women.
- 25 July 2022
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 7_2022
Application of a noninvasive prenatal test in the Yamal-Nenets Autonomous Area
- 25 July 2022
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 7_2022
Application of a noninvasive prenatal test in the Yamal-Nenets Autonomous Area
- Open Access
- 25 April 2022
- Published by Springer Nature in Research Square
Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12700 pregnancies
BackgroundA fast adoption of a non–invasive prenatal testing (NIPT) in clinical practice is a global tendency last years. The aim of the study - to assess efficiency of using NIPT as a second-line first trimester screening test in Moscow.MethodsBased on the results of the first trimester combined prenatal screening 12700 pregnant women were classified as a high-risk (cut-off ≥1:100) and an intermediate-risk (cut-off 1:101 – 1:2500) groups followed by whole genome NIPT. Women from high-risk group and those who had positive NIPT results were considered for invasive prenatal diagnostic. Results258 (2,0%) samples with positive NIPT results were detected including 126 cases of trisomy 21 (T21), 40 cases of T18, 12 cases of T13, 41 cases of sex chromosome aneuploidies (SCAs) and 39 cases of rare autosomal aneuploidies (RAAs) and significant copy number variations (CNVs). Statistically significant associations (pConclusionsNIPT demonstrated high sensitivity and specificity. As a second-line screening test it has shown high efficiency in detecting fetus chromosomal anomalies as well as it could potentially lower the number of invasive procedures in pregnant women.
- 25 April 2022
- Published by Springer Nature in Research Square
Open AccessWhole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12700 pregnancies
BackgroundA fast adoption of a non–invasive prenatal testing (NIPT) in clinical practice is a global tendency last years. The aim of the study - to assess efficiency of using NIPT as a second-line first trimester screening test in Moscow.MethodsBased on the results of the first trimester combined prenatal screening 12700 pregnant women were classified as a high-risk (cut-off ≥1:100) and an intermediate-risk (cut-off 1:101 – 1:2500) groups followed by whole genome NIPT. Women from high-risk group and those who had positive NIPT results were considered for invasive prenatal diagnostic. Results258 (2,0%) samples with positive NIPT results were detected including 126 cases of trisomy 21 (T21), 40 cases of T18, 12 cases of T13, 41 cases of sex chromosome aneuploidies (SCAs) and 39 cases of rare autosomal aneuploidies (RAAs) and significant copy number variations (CNVs). Statistically significant associations (pConclusionsNIPT demonstrated high sensitivity and specificity. As a second-line screening test it has shown high efficiency in detecting fetus chromosomal anomalies as well as it could potentially lower the number of invasive procedures in pregnant women.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 27 (1)
Random findings in the use of a whole genome noninvasive prenatal test: clinical and ethical aspects
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 27 (1)
Random findings in the use of a whole genome noninvasive prenatal test: clinical and ethical aspects
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 27 (1)
First results of non-invasive prenatal testing adoption in Moscow
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 27 (1)
First results of non-invasive prenatal testing adoption in Moscow